These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28549679)

  • 21. Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarray.
    Kellerman DJ; Ameri M; Tepper SJ
    Pain Manag; 2017 Nov; 7(6):559-567. PubMed ID: 28741429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.
    Shelke S; Shahi S; Jalalpure S; Dhamecha D
    J Liposome Res; 2016 Dec; 26(4):313-23. PubMed ID: 26758957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Brain Targeting Potential of Zolmitriptan Mucoadhesive Nanoparticles for Intranasal Drug Delivery.
    Jha S; Mishra D
    Pharm Nanotechnol; 2022; 10(2):113-124. PubMed ID: 35240970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence study of 2 orodispersible formulations of zolmitriptan 5 mg in healthy volunteers.
    Cánovas M; Canals M; Polonio F; Cabré F
    Arzneimittelforschung; 2012 Oct; 62(10):482-6. PubMed ID: 22918855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.
    Pitta SK; Dudhipala N; Narala A; Veerabrahma K
    Drug Dev Ind Pharm; 2018 Mar; 44(3):484-492. PubMed ID: 29124986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment Of Spanlastic Vesicles Of Zolmitriptan For Treating Migraine In Rats.
    El-Nabarawy NA; Teaima MH; Helal DA
    Drug Des Devel Ther; 2019; 13():3929-3937. PubMed ID: 31819367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newer formulations of the triptans: advances in migraine management.
    Gladstone JP; Gawel M
    Drugs; 2003; 63(21):2285-305. PubMed ID: 14524731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
    Gavini E; Rassu G; Ferraro L; Beggiato S; Alhalaweh A; Velaga S; Marchetti N; Bandiera P; Giunchedi P; Dalpiaz A
    Eur J Pharm Biopharm; 2013 Feb; 83(2):174-83. PubMed ID: 23153670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers.
    Yates R; Nairn K; Dixon R; Seaber E
    J Clin Pharmacol; 2002 Nov; 42(11):1237-43. PubMed ID: 12412822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.
    Abdou EM; Kandil SM; Miniawy HMFE
    Int J Pharm; 2017 Aug; 529(1-2):667-677. PubMed ID: 28729175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug.
    Abdou EM; Kandil SM; Morsi A; Sleem MW
    Drug Deliv; 2019 Dec; 26(1):689-699. PubMed ID: 31274014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics and effects on blood pressure of multiple doses of the novel anti-migraine drug zolmitriptan (311C90) in healthy volunteers.
    Dixon R; Gillotin C; Gibbens M; Posner J; Peck RW
    Br J Clin Pharmacol; 1997 Mar; 43(3):273-81. PubMed ID: 9088582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.
    Vyas TK; Babbar AK; Sharma RK; Misra A
    J Drug Target; 2005 Jun; 13(5):317-24. PubMed ID: 16199375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic evaluation of matrix effect and cross-talk-free method for simultaneous determination of zolmitriptan and N-desmethyl zolmitriptan in human plasma: a sensitive LC-MS/MS method validation and its application to a clinical pharmacokinetic study.
    Patel B; Suhagia BN; Jangid AG; Mistri HN; Desai N
    Biomed Chromatogr; 2016 Mar; 30(3):447-58. PubMed ID: 26189757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, pharmacodynamics, and safety of the 5-HT(1B/1D) agonist eletriptan following intravenous and oral administration.
    Milton KA; Scott NR; Allen MJ; Abel S; Jenkins VC; James GC; Rance DJ; Eve MD
    J Clin Pharmacol; 2002 May; 42(5):528-39. PubMed ID: 12017347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of combinational intranasal drug delivery system for the management of migraine by using statistical design.
    Kumar A; Garg T; Sarma GS; Rath G; Goyal AK
    Eur J Pharm Sci; 2015 Apr; 70():140-51. PubMed ID: 25676136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and evaluation of zolmitriptan submicron emulsion for rapid and effective nasal absorption in beagle dogs.
    Yu C; Gu P; Zhang W; Qi N; Cai C; He H; Tang X
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1509-16. PubMed ID: 21671836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic comparisons of tail-bleeding with cannula- or retro-orbital bleeding techniques in rats using six marketed drugs.
    Hui YH; Huang NH; Ebbert L; Bina H; Chiang A; Maples C; Pritt M; Kern T; Patel N
    J Pharmacol Toxicol Methods; 2007; 56(2):256-64. PubMed ID: 17618130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines.
    Lionetto L; Casolla B; Mastropietri F; D'Alonzo L; Negro A; Simmaco M; Martelletti P
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):1043-50. PubMed ID: 22762358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myalgia and cramps associated with zolmitriptan.
    Alonso-Navarro H; Jiménez-Jiménez FJ
    Clin Neuropharmacol; 2005; 28(5):241-2. PubMed ID: 16239765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.